Free Trial
NASDAQ:UTMD

Utah Medical Products Q3 2024 Earnings Report

Utah Medical Products logo
$56.43 -0.78 (-1.36%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$56.30 -0.13 (-0.23%)
As of 07/11/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Utah Medical Products EPS Results

Actual EPS
$1.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Utah Medical Products Revenue Results

Actual Revenue
$10.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Utah Medical Products Announcement Details

Quarter
Q3 2024
Time
Before Market Opens
Conference Call Date
Tuesday, October 29, 2024
Conference Call Time
9:30AM ET

Upcoming Earnings

Utah Medical Products' Q2 2025 earnings is scheduled for Thursday, July 24, 2025, with a conference call scheduled at 9:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Utah Medical Products Earnings Headlines

UTMD Utah Medical Products, Inc. - Seeking Alpha
Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
See More Utah Medical Products Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Utah Medical Products? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Utah Medical Products and other key companies, straight to your email.

About Utah Medical Products

Utah Medical Products (NASDAQ:UTMD) (NASDAQ: UTMD) is a healthcare company specializing in the design, manufacture and distribution of single‐use medical devices and accessories. Since its founding in 1972, the company has focused on niche products used in infusion therapy, blood sampling and related procedures. Key offerings include safety lancets, IV catheters, blood tubing sets, prefilled flush syringes and specialty components for use in hospital, clinical and home healthcare environments.

Headquartered in Midvale, Utah, Utah Medical Products operates a manufacturing facility that integrates plastic injection molding, precision machining and assembly capabilities. The company’s vertically integrated model enables stringent quality control, design flexibility and rapid response to customer requirements. Products are distributed through a network of domestic and international distributors and direct‐sales teams, serving hospitals, clinics, laboratories and home infusion providers across North America, Europe and select markets in Asia.

Over the years, Utah Medical Products has expanded its product portfolio through internal development and strategic partnerships, emphasizing safety features such as passive and active needle‐retraction mechanisms. This focus on clinician and patient safety supports compliance with government regulations and industry standards. In addition to standard product lines, the company provides custom molding and contract‐manufacturing services, leveraging its expertise in medical‐grade materials and regulatory documentation to meet customer‐specific needs.

Leadership at UTMD is headed by President and Chief Executive Officer John T. Carter, who has guided the company’s growth and operational strategy for more than a decade. The management team includes experienced professionals in engineering, quality assurance, sales and finance, supported by a board of directors with deep expertise in medical devices and healthcare distribution. Through ongoing investments in R&D, manufacturing efficiency and global distribution, Utah Medical Products continues to pursue opportunities in emerging markets and evolving clinical best practices.

View Utah Medical Products Profile

More Earnings Resources from MarketBeat